Cecilia López Sambrooks

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index269citations34works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycosylation and Glycoproteins Research(21), Peptidase Inhibition and Analysis(12), HER2/EGFR in Cancer Research(10), Protein Tyrosine Phosphatases(10), Lung Cancer Treatments and Mutations(9)

Publications34 total

Supplementary Data from Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
2023Open Access
Data from Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
2023Open Access
Data from Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
2023Open Access
Supplementary Data from Neuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
2023Open Access
Suppl. Table 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Suppl. Table 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
legends from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Suppl Fig. 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
legends from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Supplementary figure 1 from Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
2023Open Access
Supplementary Table 1 from Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
2023Open Access
Suppl. Table 2 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Suppl Fig. 1 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
legends from Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
2023Open Access
Suppl Fig. 2 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Supplementary figure 2 from Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
2023Open Access
Data from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Supplementary figure 2 from Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
2023Open Access
Suppl. Table 2 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
Suppl Fig. 2 from Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
2023Open Access
page 1 of 2Next →

Frequent Co-authors

Joseph N. Contessa(31), Marta Baro(29), Amanda Quijano(24), W. Mark Saltzman(24), Azeet Narayan(13), Patricia Greninger(13), Regina K. Egan(13), Abhijit A. Patel(13), Cyril H. Benes(13), Wei Cui(12), Barbara Burtness(5), Mark A. Lemmon(5), Marcos A. Carpio(3), Marta E. Hallak(3), S Durand(2), Wei Cui(1), María B. Decca(1), Guillermo G. Montich(1), Aurélie Cazet(1), Jonathan Charest(1)